China’s Food and Beverage Industry in Search of Methods to Shrink its Carbon Footprints
Biotech Astrabio Nets Nearly CNY 100 Mn in Series A financing Round
Astrabio, specializing in the Single Molecule Counting technology, will continue to promote the revolution of the next-generation immunoassay technology by further accelerating the R&D and clinical translation of new biomarkers with the fresh proceeds.
Updated 9 hours ago
Biotech Firm ImmuneOnco Submitted Listing Application on the Main Board of HKEX
ImmuneOnco, focusing on developing new-generation tumor immunotherapeutic, will further accelerate the development of other promising drug candidates targeting checkpoints of innate and adaptive immunity.
Jun 28, 2022 10:58 PM